However, given the neutral effect of GLP-1 RAs on surrogate HF outcomes in HFrEF and a potentially increased risk of arrhythmias and HF-related hospitalisations, conducting further large-scale trials in the HFrEF cohort seems complicated
Timothy Garvey, MD Professor of Medicine University of Alabama at Birmingham, Birmingham, Alabama, USA Director, UAB Diabetes Research Center Dr
9 Does Wegovy affect my bones
Some cosmetic companies market AHK-Cu as a next-generation copper peptide with improved stability, but these claims have not been rigorously validated in independent comparative studies
With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures